Nomura Holdings’s Cantel Medical Corporation CMD Stock Holding History

Nomura Holdings’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,000	Closed	-$1.04M	–	2610
2021 Q1	$1.04M	Buy	+13,000	New	+$1.02M	﹤0.01%	1078
2017 Q4	–	Sell	-2,267	Closed	-$212K	–	1742
2017 Q3	$212K	Buy	+2,267	New	+$179K	﹤0.01%	1412
2017 Q2	–	Sell	-3,073	Closed	-$246K	–	1661
2017 Q1	$246K	Buy	3,073 +535	+21%	+$42.5K	﹤0.01%	1122
2016 Q4	$200K	Buy	+2,538	New	+$197K	﹤0.01%	1435
2016 Q1	–	Sell	-8,554	Closed	-$532K	–	2135
2015 Q4	$532K	Buy	+8,554	New	+$522K	﹤0.01%	1042
2014 Q1	–	Sell	-10,422	Closed	-$354K	–	2984
2013 Q4	$354K	Sell	10,422 -205	-2%	-$7.1K	﹤0.01%	1453
2013 Q3	$337K	Buy	+10,627	New	+$283K	﹤0.01%	1619

Nomura Holdings's CMD Position: Q2 2021 in Review

Nomura Holdings sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 13,000 shares — an estimated $1.04M sold.

Nomura Holdings first reported a position in CMD in Q3 2013 and held it in 7 quarters. The position peaked at $1.04M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Nomura Holdings reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Nomura Holdings sold 13,000 Cantel Medical Corporation shares in Q2 2021, an estimated $1.04M.
Nomura Holdings first reported a position in Cantel Medical Corporation in Q3 2013 and held it in 7 quarters.
Nomura Holdings's Cantel Medical Corporation position peaked at $1.04M in Q1 2021.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Nomura Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.